Diffuse choroidal hemangioma (DCH), a feature of Sturge-Weber syndrome, is most often treated with whole-eye radiotherapy at stage of complications such as retinal detachment.
Methods
This is a case report of a 17-year-old boy with DCH and exudative retinal detachment.
Results
The patient was treated with propranolol at 60 mg twice a day for 2 months followed by gradual dose taper to 10 mg twice a day per month and discontinued at 7 months. The retinal detachment slowly resolved over 1 month and the retina remained attached at 10 months follow-up. There were no medication side effects.
Conclusions
We suggest that oral propranolol be considered in the armamentarium for selected DCH.
ShieldsJ.A., ShieldsC.L.. Vascular tumors and malformation of the uvea. In: ShieldsJ.A., ShieldsC.L.. Intraocular Tumors: An Atlas and Textbook, second ed. Baltimore: Lippincott Williams & Wilkins; 2008: 230–51.
2.
TsipurskyM.S., GolchetP.R., JampolL.M.. Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol2011; 56: 68–85.
3.
ArevaloJ.F., AriasJ.D., SerranoM.A.. Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma [letter]. Arch Ophthalmol2011; 129: 1373–5.
4.
Sanz-MarcoE., GallegoR., Diaz-LlopisM.. Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol2011; 2: 84–90.
5.
MadreperlaS.A., HungerfordJ.L., PlowmanP.N., LaganowskiH.C., GregoryP.T.. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology1997; 104: 1773–9.
6.
SchillingH., SauerweinW., LommatzschA.. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol1997; 81: 267–73.
7.
GiatromanolakiA., ArvanitidouV., HatzimichaelA., SimopoulosC., SivridisE.. The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas. Pathology2005; 37: 149–51.
